Dear editor,

The COVID-19 pandemic caused the cancellation of all elective surgeries in New York State; nevertheless, non-elective surgeries still needed to be performed. The mortality and morbidity associated with a hip fracture is reduced if repair occurs within 48 h of admission \[[@bb0005]\]. Two international case series demonstrated elevated risk for perioperative morbidity and mortality following hip fracture repair in coronavirus patients \[[@bb0010],[@bb0015]\]. On the contrary, we describe the successful management of five COVID-19 patients who underwent surgery.

After institutional review board (\#2020-11706) approval at Montefiore Medical Center, a retrospective case series of patients undergoing surgical repair of a hip fracture between March 19, 2020 and April 30, 2020 was performed. *Written consent to publish the case was obtained from patients.*

Four patients presented with intertrochanteric (IT) fractures and one patient had a femoral neck fracture. Demographic information and a description of the surgical management are detailed in [Table 1](#t0005){ref-type="table"} . All five patients presented with mild to moderate COVID-19 symptoms with some elevation of inflammatory markers (Ferritin in patients \#2 and \#3 and C-reactive protein in patients \#2, \#3, and \#5). Hypercoagulability was demonstrated by an elevated D-dimer on the day of surgery in four patients. Prior to admission patient \#5 was on Clopidogrel for peripheral vascular disease which was converted to therapeutic Enoxaparin on hospital admission and then continued postoperatively. The remaining three patients were started on Enoxaparin daily preoperatively and continued postoperatively. On postoperative day 5, patient \#3 required dialysis and Enoxaparin was converted to Apixiban as per Hematology COVID-19 guidelines at our institution. Hemoglobin levels were maintained above 8 × 10^9^/L. Treatment of the hypercoagulable state with heparin has been shown to improve overall survival \[[@bb0020]\]. Patients should be placed on chemoprophylaxis if not contraindicated preoperatively and resumed on postoperatively. Low molecular weight heparin is preferred. In situations where heparin is contraindicated, non-heparin anticoagulation agents should be used.Table 1Clinical characteristics and outcomes of COVID-19 positive patients with hip fractures.Table 1Patient 1Patient 2Patient 3Patient 4Patient 5Clinical characteristics Age (years), sex76, F67, M80, F89, F83, F BMI (kg/m^2^)3228222424 Orthopedic diagnosisFemoral neck fractureIntertrochanteric fractureIntertrochanteric fractureIntertrochanteric fractureIntertrochanteric fracture w/ subtrochanteric extension Type of surgeryUncemented hip HAShort IMNShort IMNShort IMNLong IMN Type of anesthesiaGeneral anesthesiaSpinalSpinalSpinalSpinalComorbidities DiabetesYesYesNoYesNo HTNYesYesYesYesYes Obesity (\>30 BMI)YesNoNoYesNo Low ejection fraction (\<50%)NoNoNoYesNo Heart disease (CAD, Pacemaker, dysrhythmia)YesNoNoYesNo DementiaYesNoNoNoYes Renal diseaseYesNoYes, on HDYesNo AnemiaYesYesYesYesYes COPDNoYesNoYesNo AsthmaYesNoNoYesNo AnticoagulationYes - Apixaban & Heparin dripNoNoNoYes - Clopidogrel SmokingNoYesNoYesNo Psychiatric issuesNoYesNoYesYes Peripheral vascular diseaseYesNoNoYesYes StrokeNoNoNoNoYesSigns and Symptoms FeverYesNoNoNoNo CoughNoNoNoNoNo Low oxygenation (\<95%)YesYesYesNoYes DyspneaNoNoNoNoNoLaboratory test results White blood cell count (X10^9^/L)10.89.414.1 (↑)8.58.2 Red blood cell count (x10^9^/L)3.13 (↓)3.58 (↓)2.85 (↓)3.41 (↓)4.48 Neutrophil count (x10^9^/L)6.37.211.4 (↑)8.15.6 Hemoglobin[a](#tf0005){ref-type="table-fn"} (x10^9^/L)9.0 (↓)10.0 (↓)8.2 (↓)9.3 (↓)8.6 (↓) Platelet count (x10^9^/L)380187111 (↓)354228 PT (s)16.4 (↑)14.9 (↑)14.31415.5 (↑) PTT (s)32.73739.729.633.9 INR (ratio)1.31.11.11.11.2 D-dimer[b](#tf0010){ref-type="table-fn"} (μg/mL)N/A7.76 (↑)5.92 (↑)9.42 (↑)4.46 (↑) Lactic dehydrogenase (U/L)253 (↑)242 (↑)396 (↑)247 (↑)273 (↑) BUN (mmol/L)25 (↑)23 (↑)38 (↑)49 (↑)12 Creatinine (μmol/L)1.021.055.85 (↑)1.20.45 C-reactive protein (mg/dL)N/A8.8 (↑)3.5 (↑)0.110.4 (↑) Procalcitonin (ng/mL)N/A0.2 (↑)0.9 (↑)0.10.2 (↑) Ferritin (ng/ml)1591725 (↑)508 (↑)146173Evidence of COVID-19 SARS-COV-2 quantitative RT-PCRPositivePositivePositivePositivePositive Chest x-rayBilateral opacitiesBilateral opacitiesBilateral opacities/lung metsNo opacitiesNo opacitiesTreatments Oxygen therapy (NC, BIPAP)YesYesNoNoYes AntibioticsYesNoNoNoNo AnticoagulationYes - ApixabanYes - LMWHYes - LMWH & ApixabanYes - LMWHYes - LMWH HydrochloroquineYesNoNoNoNo Antiviral therapyNoNoNoNoNo Glucocorticoid therapyNoNoNoNoNo DialysisNoNoYesNoNo Mechanical ventilationNoNoNoNoNoComplications post-surgery Co-bacterial pneumonia/infectionNoNoNoNoNo Thrombotic eventNoNoNoNoNo Need for PRBC transfusionYesYesYesYesYes DeathNoNoNoNoNo Time of surgery post admission (hours)4824\>7224\>72 Length of hospitalization (days)15911811 Discharged from hospital (days)Yes - SARYes - SARYes - SARYes - SARYes - NH[^1][^2][^3]

Regional anesthesia has been shown to be safe in COVID-19 patients \[[@bb0025]\]. Spinal anesthesia was utilized in order to decrease the risk of viral aerosolization. Short cephalomedullary nail was used in three of the four patients with IT fracture to decrease surgery time and blood loss; subtrochanteric extension prevented its use in the fourth patient. The femoral neck fracture patient underwent uncemented hemiarthroplasty to reduce the risk of cardiopulmonary complications. General anesthesia was used due to heparin drip. Furthermore, early mobilization and rehabilitation of the post-surgical COVID-19 patient is recommended to improve functional status.

Tranexamic acid (TXA) is commonly used to limit blood loss for elective hip surgeries. Its efficacy and safety have been demonstrated in many studies on patients with minimal comorbidities, but there is limited data on patients at high-risk for thromboembolic events with COVID-19 infection. Thus, the routine use of TXA for this population is not recommended. Postoperative delirium is associated with poor surgical outcomes, underscoring the importance of multimodal analgesia for pain. The clinical presentation of patients with COVID-19 can vary from asymptomatic to critically ill. The severity of infection correlates with the elevation of biological markers. Based on our experiences, surgical repair should be reserved for patients with either mild or moderate symptoms.

Hip fractures typically occur in the elderly population and are complicated by multiple comorbidities. Active COVID-19 infection places these patients at increased risk for morbidity and mortality. Timely repair is preferable; however, in this case series we have shown that delayed surgical repair can also result in good surgical outcomes. Further research is needed to better establish surgical guidelines in the care of COVID-19 patients presenting with hip fractures, including how the surgical plan should be altered based on the severity of infection.\\
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[^1]: HA = hemiarthroplasty, IMN = intramedullary nail, BMI = body mass index, HTN = hypertension, COPD = chronic obstructive pulmonary disease, CAD = coronary artery disease, HD = hemodialysis, BUN = blood urea nitrogen, N/A = not available, Ferritin: normal range 25-270 ng/ml, SARS-COV-2 = severe acute respiratory syndrome coronavirus 2, RT-PCR = reverse transcription polymerase chain reaction, NC = nasal cannula, BIPAP = bilevel positive airway pressure, PRBC = packed red blood cells, PT = prothrombin time, PTT = partial thromboplastin time, INR = international normalized ratio, LMWH = low molecular weight heparin, SAR = subacute rehab, NH = nursing home.

[^2]: Hemoglobin: normal range 12.2-15.3g/dl.

[^3]: D-dimer: normal range 0.0-0.5μg/ml.
